Lifeflexi·Nov 2Bland-Altman Agreement Analysis in Clinical MeasurementBiostatistics * Clinical Measurement * November 2, 2026A response icon1A response icon1
Lifeflexi·Oct 29Micro-Randomized Trials for JITAI Clinical ResearchClinical Trial Design * Digital Health Methods * October 29, 2026
Lifeflexi·Oct 27Principal Stratification for Clinical Trial EstimandsPrincipal stratification defines latent subgroups by participants’ joint potential outcomes for a post-randomization variable. It can…
Lifeflexi·Oct 26Flexible Parametric Survival Models: Royston-ParmarFlexible parametric survival models, especially the Royston-Parmar model, use restricted cubic splines to model the baseline survival…
Lifeflexi·Oct 20Bayesian Additive Regression Trees in Clinical ResearchBayesian Additive Regression Trees (BART) combine many regularized shallow trees to estimate nonlinear relationships and interactions while…
Lifeflexi·Oct 19Zero-Inflated and Hurdle Models for Clinical CountsZero-inflated models treat observed zeros as arising from a mixture of structural and count-generating processes, whereas hurdle models use…
Lifeflexi·Oct 15Brier Score and Prediction Error Curves in Clinical ModelsThe Brier score is a proper scoring rule that summarizes the squared error of probabilistic predictions. It reflects both calibration and…
Lifeflexi·Oct 13Collider Bias in Clinical Epidemiology: DAGs and SelectionCollider bias arises when an analysis conditions on a variable influenced by both the exposure and the outcome, or by their causes…
Lifeflexi·Oct 12Pseudo-Observations for Survival and Competing-Risk RegressionPseudo-observations convert a censoring-adjusted sample-level survival quantity into subject-indexed quantities that can be modeled with…